Z-FY-CHO
Z-FY-CHO Basic information
- Product Name:
- Z-FY-CHO
- Synonyms:
-
- CATHEPSIN L INHIBITOR II
- Z-Phe-Tyr-al
- Z-PHE-TYR-ALDEHYDE
- Z-PHE-TYR-CHO
- Z-FY-CHO
- Carbamic acid, N-[(1S)-2-[[(1S)-1-formyl-2-(4-hydroxyphenyl)ethyl]amino]-2-oxo-1-(phenylmethyl)ethyl]-, phenylmethyl ester
- Z-L-PHE-L-TYR-ALDEHYDE
- Cathepsin L inhibitor inhibitor
- CAS:
- 167498-29-5
- MF:
- C26H26N2O5
- MW:
- 446.49
- Mol File:
- 167498-29-5.mol
Z-FY-CHO Chemical Properties
- Boiling point:
- 726.5±60.0 °C(Predicted)
- Density
- 1.249±0.06 g/cm3(Predicted)
- storage temp.
- -15°C
- solubility
- Soluble in DMSO (up to 30 mg/ml) or in Ethanol (up to 50 mg/ml)
- pka
- 9.87±0.15(Predicted)
- form
- solid
- color
- Off-white to pale yellow
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 1 month.
Z-FY-CHO Usage And Synthesis
Description
Z-Phe-Tyr-CHO (167498-29-5) is a potent and selective inhibitor of cathepsin L, IC50=0.85 nM 1 selective over ?cathepsin B and calpain II (IC50s=85.1 and 184 nM respectively). Suppresses osteoclastic ?pit formation at 1.5 nM and markedly inhibited parathyroid hormone-stimulated osteoclastic bone resorption.2 Also inhibits cathepsin K (Kis=0.052 and 1.57 nM for cat L and cat K respectively) and partially provides the basis for the finding that cathepsin K is the protease responsible for osteoclastic bone resorption.3 Provides partial protection against serum and potassium deprivation-induced neuronal death.4 Active in vivo.2
Uses
Z-Phe-Tyr-aldehyde is a cathepsin L inhibitor useful in the study of human osteoclast resorption and drug development for the treatment of coronavirus disease.
in vivo
Intraperitoneal administration of Z-FY-CHO (2.5-10 mg/kg) for 4 weeks suppresses bone weight loss dose dependently in the ovariectomized mouse, experimental model of osteoporosis. Z-FY-CHO acts as a bone resorption suppressor through the inhibition of collagen degradation[3].
IC 50
cathepsin L
References
[1] JE-TAE WOO. Peptidyl aldehyde derivatives as potent and selective inhibitors of cathepsin L[J]. Bioorganic & Medicinal Chemistry Letters, 1995, 5 14: Pages 1501-1504. DOI:10.1016/0960-894x(95)00236-m
[2] JE-TAE WOO . Suppressive effect of N-(benzyloxycarbonyl)-l-phenylalanyl-l-tyrosinal on bone resorption in vitro and in vivo[J]. European journal of pharmacology, 1996, 300 1: Pages 131-135. DOI:10.1016/0014-2999(95)00858-6
[3] I E JAMES. Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro.[J]. The Journal of Biological Chemistry, 2001, 276 15: 11507-11511. DOI:10.1074/jbc.m010684200
[4] ALLEN KAASIK. Up-regulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium[J]. European Journal of Neuroscience, 2005, 22 5: 1023-1031. DOI:10.1111/j.1460-9568.2005.04279.x
Z-FY-CHOSupplier
- Tel
- 21-61263452 13641803416
- ymbetter@glbiochem.com
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 1-631-485-4226; 16314854226
- info@bocsci.com
- Tel
- +86-21-61263340; 17609490614 13764994101
- fisherwang@glschina.com